| Literature DB >> 30466669 |
Abstract
Colonoscopy with polypectomy is the means by which the incidence of colon cancer may be reduced; however, polypectomy is not without risk. Physicians must carefully weigh the risks and benefits of colonoscopy, particularly when patients are given prescriptions for antiplatelet agents and anticoagulants. This article discusses the risks of colonoscopy and polypectomy and reviews the most recent data for managing antiplatelet agents and anticoagulants in the periendoscopic period. Published by Elsevier Inc.Entities:
Keywords: Anticoagulants; Antiplatelet agents; Colonoscopy; Gastrointestinal hemorrhage; Polypectomy; Risks
Mesh:
Substances:
Year: 2018 PMID: 30466669 DOI: 10.1016/j.mcna.2018.08.003
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456